Impact of the Mylife CamAPS FX System With the DEXCOM G6 Sensor on T1D Patients in France

Exclusion Criteria

• •Patient who used a hybrid closed-loop system, a fully closed-loop system, or a do-it-yourself loop system, regardless of the brand or model, within the past 6 months.
• •Patients participating or having participated in a clinical trial in the previous month that prevents them from participating in other studies.
• •Patient or parent unable to give consent.
• •Protected Patient (subject to a legal protection measure: guardianship, curatorship or legal safeguard).
• •Patient with a contraindication to the prescription of the mylife CamAPS FX hybrid closed-loop ( according to the Instructions For Use, IFU).
• •Patient with an unresolved skin condition in the area of sensor placement and/or in the tubing placement area (e.g. psoriasis, dermatitis herpetiformis, rash, staphylococcal infection).
• •Patient with unstable diabetic retinopathy requiring laser treatment.
• •Patient with a concomitant condition or treatment that alters glucose metabolism and that, in the investigator's judgment, is likely to have a significant impact on glycemic control;
• •Patient whose follow-up cannot be carried out by the centre (relocation planned within 12 months of inclusion).